Not Yet RecruitingNot Applicable

Assessing the Burden of Respiratory Syncytial Virus (RSV)

United Arab Emirates1,500 participantsStarted 2025-06

Plain-language summary

This study examines the impact of Respiratory Syncytial Virus (RSV) on people of all ages, from infants to the elderly. It uses hospital records collected between January 2018 and December 2024 to understand: * How often does RSV occur * Who is most at risk * The long-term and financial effects of RSV

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients of all ages with a confirmed diagnosis of RSV infection * Patients admitted to a SEHA hospital or healthcare facility between January 2018 and December 2024 * Patients with documented data in the SEHA electronic medical record (EMR) system Exclusion Criteria: * Patients with suspected RSV infection that is not laboratory-confirmed * Patients without sufficient data in the SEHA EMR system

What they're measuring

Burden of RSV Infection Across All Age Groups

Timeframe: January 2018 - December 2024

Burden of RSV Infection Across All Age Groups

Timeframe: January 2018 - December 2024

Trial details

NCT IDNCT07015255

SponsorAbu Dhabi Health Services Company

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2026-06

Contact for this trial

Lina Khairy, MD

+971589111897 o-lkhayri@seha.ae

View on ClinicalTrials.gov More Respiratory Syncytial Virus (RSV) Infection trials